Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)

Citations Over TimeTop 10% of 2001 papers

Abstract

Memapsin 2 (beta-secretase) is one of two proteases that cleave the beta-amyloid precursor protein (APP) to produce the 40-42 residue amyloid-beta peptide (Abeta) in the human brain, a key event in the progression of Alzheimer's disease. On the basis of the X-ray crystal structure of our lead inhibitor (2, OM99-2 with eight residues) bound to memapsin, we have reduced the molecular weight and designed potent memapsin inhibitors. Structure-based design and preliminary structure-activity studies have been presented.

Related Papers

• → Inhibition of amyloid precursor protein processing by β-secretase through site-directed antibodies(2005)76 cited
• → Rac1 changes the substrate specificity of γ-secretase between amyloid precursor protein and Notch1(2008)32 cited
• → Inhibition of amyloid β‐peptide production by blockage of β‐secretase cleavage site of amyloid precursor protein(2007)14 cited
• → Destruxin E Decreases Beta-Amyloid Generation by Reducing Colocalization of Beta-Amyloid-Cleaving Enzyme 1 and Beta-Amyloid Protein Precursor(2009)13 cited
• → Trafficking and Proteolytic Processing of APP(2012)1,060 cited